AMPATH Lilly Partnership Grows to Reach More People

For more than 15 years, Eli Lilly and Company and the Lilly Foundation have partnered with AMPATH to provide medicines and care to people living in Western Kenya. The partnership began with product donations for diabetes, then grew to include medicines for mental illness and cancer.

Prior to the partnership, people were all too frequently turned away in AMPATH clinics due to the lack of medicine.

AMPATH was created in 2001 in response to the HIV crisis. What started as a small team has grown into a global partnership between academic institutions in Kenya, North America and around the world. Today, AMPATH serves a population of more than 4 million people in Kenya at more than 500 clinical sites – from village health centers and dispensaries to county hospitals to the Moi Teaching and Referral Hospital in Eldoret, where AMPATH is located.

Since 2002, Lilly has committed nearly $150 million in product donations to AMPATH. The company works with its PQMD partner, Catholic Medical Mission Board (CMMB), to facilitate the donations.

There can be challenges associated with shipments and deliveries of this magnitude. Lilly and AMPATH have worked diligently with the Kenyan government and other organizations to improve the process and minimize delays. The latest shipment is being coordinated now.

Beyond product donations from the company, the Lilly Foundation provided a $1 million grant to AMPATH in 2015 to help equip the Chandaria Cancer and Chronic Diseases Center, hire additional staff and train local oncology healthcare professionals. The foundation provided an additional $3.5 million grant to fund breast and cervical cancers screenings, which have reached 35,000 people to date.

Lilly also sends employees to volunteer with AMPATH through the company’s Connecting Hearts Abroad program. Employees help support AMPATH’s mobile screening efforts that help people like Nancy Odari, a mother of two and a pastor at her local church.

Like they have for more than 15 years, AMPATH and Lilly continue to search for additional opportunities to help more people in Kenya – and beyond.